Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

Error occurred: cannot get document summary

PMID:
30227708

2.

AGuIX® from bench to bedside-Transfer of an ultrasmall theranostic gadolinium-based nanoparticle to clinical medicine.

Lux F, Tran VL, Thomas E, Dufort S, Rossetti F, Martini M, Truillet C, Doussineau T, Bort G, Denat F, Boschetti F, Angelovski G, Detappe A, Crémillieux Y, Mignet N, Doan BT, Larrat B, Meriaux S, Barbier E, Roux S, Fries P, Müller A, Abadjian MC, Anderson C, Canet-Soulas E, Bouziotis P, Barberi-Heyob M, Frochot C, Verry C, Balosso J, Evans M, Sidi-Boumedine J, Janier M, Butterworth K, McMahon S, Prise K, Aloy MT, Ardail D, Rodriguez-Lafrasse C, Porcel E, Lacombe S, Berbeco R, Allouch A, Perfettini JL, Chargari C, Deutsch E, Le Duc G, Tillement O.

Br J Radiol. 2018 Sep 18:20180365. doi: 10.1259/bjr.20180365. [Epub ahead of print]

PMID:
30226413
3.

Measuring glucocorticoid receptor expression in vivo with PET.

Truillet C, Parker MFL, Huynh LT, Wei J, Jami KM, Wang YH, Shen YS, Sriram R, Wilson DM, Kurhanewicz J, Evans MJ.

Oncotarget. 2018 Apr 17;9(29):20399-20408. doi: 10.18632/oncotarget.24911. eCollection 2018 Apr 17.

4.

Development of a stress response therapy targeting aggressive prostate cancer.

Nguyen HG, Conn CS, Kye Y, Xue L, Forester CM, Cowan JE, Hsieh AC, Cunningham JT, Truillet C, Tameire F, Evans MJ, Evans CP, Yang JC, Hann B, Koumenis C, Walter P, Carroll PR, Ruggero D.

Sci Transl Med. 2018 May 2;10(439). pii: eaar2036. doi: 10.1126/scitranslmed.aar2036.

PMID:
29720449
5.

Longitudinal positron emission tomography imaging of glial cell activation in a mouse model of mesial temporal lobe epilepsy: Toward identification of optimal treatment windows.

Nguyen DL, Wimberley C, Truillet C, Jego B, Caillé F, Pottier G, Boisgard R, Buvat I, Bouilleret V.

Epilepsia. 2018 Jun;59(6):1234-1244. doi: 10.1111/epi.14083. Epub 2018 Apr 19.

PMID:
29672844
6.

Targeting RAS-driven human cancer cells with antibodies to upregulated and essential cell-surface proteins.

Martinko AJ, Truillet C, Julien O, Diaz JE, Horlbeck MA, Whiteley G, Blonder J, Weissman JS, Bandyopadhyay S, Evans MJ, Wells JA.

Elife. 2018 Jan 23;7. pii: e31098. doi: 10.7554/eLife.31098.

7.

Metabolic reprogramming ensures cancer cell survival despite oncogenic signaling blockade.

Lue HW, Podolak J, Kolahi K, Cheng L, Rao S, Garg D, Xue CH, Rantala JK, Tyner JW, Thornburg KL, Martinez-Acevedo A, Liu JJ, Amling CL, Truillet C, Louie SM, Anderson KE, Evans MJ, O'Donnell VB, Nomura DK, Drake JM, Ritz A, Thomas GV.

Genes Dev. 2017 Oct 15;31(20):2067-2084. doi: 10.1101/gad.305292.117. Epub 2017 Nov 14.

8.

Imaging PD-L1 Expression with ImmunoPET.

Truillet C, Oh HLJ, Yeo SP, Lee CY, Huynh LT, Wei J, Parker MFL, Blakely C, Sevillano N, Wang YH, Shen YS, Olivas V, Jami KM, Moroz A, Jego B, Jaumain E, Fong L, Craik CS, Chang AJ, Bivona TG, Wang CI, Evans MJ.

Bioconjug Chem. 2018 Jan 17;29(1):96-103. doi: 10.1021/acs.bioconjchem.7b00631. Epub 2017 Nov 15.

9.

Development of 5N-Bicalutamide, a High-Affinity Reversible Covalent Antiandrogen.

de Jesus Cortez F, Nguyen P, Truillet C, Tian B, Kuchenbecker KM, Evans MJ, Webb P, Jacobson MP, Fletterick RJ, England PM.

ACS Chem Biol. 2017 Dec 15;12(12):2934-2939. doi: 10.1021/acschembio.7b00702. Epub 2017 Nov 2.

PMID:
28981251
10.

68Ga-radiolabeled AGuIX nanoparticles as dual-modality imaging agents for PET/MRI-guided radiation therapy.

Bouziotis P, Stellas D, Thomas E, Truillet C, Tsoukalas C, Lux F, Tsotakos T, Xanthopoulos S, Paravatou-Petsotas M, Gaitanis A, Moulopoulos LA, Koutoulidis V, Anagnostopoulos CD, Tillement O.

Nanomedicine (Lond). 2017 Jul;12(13):1561-1574. doi: 10.2217/nnm-2017-0032. Epub 2017 Jun 16.

11.

Real-Time Transferrin-Based PET Detects MYC-Positive Prostate Cancer.

Aggarwal R, Behr SC, Paris PL, Truillet C, Parker MFL, Huynh LT, Wei J, Hann B, Youngren J, Huang J, Premasekharan G, Ranatunga N, Chang E, Gao KT, Ryan CJ, Small EJ, Evans MJ.

Mol Cancer Res. 2017 Sep;15(9):1221-1229. doi: 10.1158/1541-7786.MCR-17-0196. Epub 2017 Jun 7.

12.

Noninvasive Measurement of mTORC1 Signaling with 89Zr-Transferrin.

Truillet C, Cunningham JT, Parker MFL, Huynh LT, Conn CS, Ruggero D, Lewis JS, Evans MJ.

Clin Cancer Res. 2017 Jun 15;23(12):3045-3052. doi: 10.1158/1078-0432.CCR-16-2448. Epub 2016 Dec 22.

13.

68Ga-PSMA-11 PET Imaging of Response to Androgen Receptor Inhibition: First Human Experience.

Hope TA, Truillet C, Ehman EC, Afshar-Oromieh A, Aggarwal R, Ryan CJ, Carroll PR, Small EJ, Evans MJ.

J Nucl Med. 2017 Jan;58(1):81-84. doi: 10.2967/jnumed.116.181800. Epub 2016 Sep 22.

14.

A reactivity-based [18F]FDG probe for in vivo formaldehyde imaging using positron emission tomography.

Liu W, Truillet C, Flavell RR, Brewer TF, Evans MJ, Wilson DM, Chang CJ.

Chem Sci. 2016 Aug 1;7(8):5503-5507. doi: 10.1039/c6sc01503d. Epub 2016 May 25.

15.

Synthesis and Characterization of (89)Zr-Labeled Ultrasmall Nanoparticles.

Truillet C, Thomas E, Lux F, Huynh LT, Tillement O, Evans MJ.

Mol Pharm. 2016 Jul 5;13(7):2596-601. doi: 10.1021/acs.molpharmaceut.6b00264. Epub 2016 Jun 14.

PMID:
27266800
16.

Site-Specific Radiofluorination of Biomolecules with 8-[(18)F]-Fluorooctanoic Acid Catalyzed by Lipoic Acid Ligase.

Drake CR, Sevillano N, Truillet C, Craik CS, VanBrocklin HF, Evans MJ.

ACS Chem Biol. 2016 Jun 17;11(6):1587-94. doi: 10.1021/acschembio.6b00172. Epub 2016 Mar 31.

17.

[(11)C]Ascorbic and [(11)C]dehydroascorbic acid, an endogenous redox pair for sensing reactive oxygen species using positron emission tomography.

Carroll VN, Truillet C, Shen B, Flavell RR, Shao X, Evans MJ, VanBrocklin HF, Scott PJ, Chin FT, Wilson DM.

Chem Commun (Camb). 2016 Apr 7;52(27):4888-90. doi: 10.1039/c6cc00895j. Epub 2016 Mar 10.

18.

Applying ⁸⁹Zr-Transferrin To Study the Pharmacology of Inhibitors to BET Bromodomain Containing Proteins.

Doran MG, Carnazza KE, Steckler JM, Spratt DE, Truillet C, Wongvipat J, Sawyers CL, Lewis JS, Evans MJ.

Mol Pharm. 2016 Feb 1;13(2):683-8. doi: 10.1021/acs.molpharmaceut.5b00882. Epub 2016 Jan 12.

19.

Caged [(18)F]FDG Glycosylamines for Imaging Acidic Tumor Microenvironments Using Positron Emission Tomography.

Flavell RR, Truillet C, Regan MK, Ganguly T, Blecha JE, Kurhanewicz J, VanBrocklin HF, Keshari KR, Chang CJ, Evans MJ, Wilson DM.

Bioconjug Chem. 2016 Jan 20;27(1):170-8. doi: 10.1021/acs.bioconjchem.5b00584. Epub 2015 Dec 22.

20.

Long-term in vivo clearance of gadolinium-based AGuIX nanoparticles and their biocompatibility after systemic injection.

Sancey L, Kotb S, Truillet C, Appaix F, Marais A, Thomas E, van der Sanden B, Klein JP, Laurent B, Cottier M, Antoine R, Dugourd P, Panczer G, Lux F, Perriat P, Motto-Ros V, Tillement O.

ACS Nano. 2015 Mar 24;9(3):2477-88. doi: 10.1021/acsnano.5b00552. Epub 2015 Feb 26.

PMID:
25703068
21.

Ultrasmall particles for Gd-MRI and (68) Ga-PET dual imaging.

Truillet C, Bouziotis P, Tsoukalas C, Brugière J, Martini M, Sancey L, Brichart T, Denat F, Boschetti F, Darbost U, Bonnamour I, Stellas D, Anagnostopoulos CD, Koutoulidis V, Moulopoulos LA, Perriat P, Lux F, Tillement O.

Contrast Media Mol Imaging. 2015 Jul-Aug;10(4):309-19. doi: 10.1002/cmmi.1633. Epub 2014 Dec 5.

PMID:
25483609
22.

Innovative multimodal DOTA/NODA nanoparticles for MRI and PET imaging for tumor detection.

Truillet C, Bouziotis P, Tsoukalas C, Sancey L, Denat F, Boschetti F, Stellas D, Anagnostopoulos CD, Koutoulidis V, Moulopoulos LA, Lux F, Perriat P, Tillement O.

EJNMMI Phys. 2014 Jul;1(Suppl 1):A80. doi: 10.1186/2197-7364-1-S1-A80. No abstract available.

23.

Advantages of gadolinium based ultrasmall nanoparticles vs molecular gadolinium chelates for radiotherapy guided by MRI for glioma treatment.

Le Duc G, Roux S, Paruta-Tuarez A, Dufort S, Brauer E, Marais A, Truillet C, Sancey L, Perriat P, Lux F, Tillement O.

Cancer Nanotechnol. 2014;5(1):4. Epub 2014 Jul 1.

24.

Coupling of HPLC with electrospray ionization mass spectrometry for studying the aging of ultrasmall multifunctional gadolinium-based silica nanoparticles.

Truillet C, Lux F, Tillement O, Dugourd P, Antoine R.

Anal Chem. 2013 Nov 5;85(21):10440-7. doi: 10.1021/ac402429p. Epub 2013 Oct 25.

PMID:
24160370
25.

Functionalization of small rigid platforms with cyclic RGD peptides for targeting tumors overexpressing αvβ3-integrins.

Morlieras J, Dufort S, Sancey L, Truillet C, Mignot A, Rossetti F, Dentamaro M, Laurent S, Vander Elst L, Muller RN, Antoine R, Dugourd P, Roux S, Perriat P, Lux F, Coll JL, Tillement O.

Bioconjug Chem. 2013 Sep 18;24(9):1584-97. doi: 10.1021/bc4002097. Epub 2013 Sep 9.

PMID:
23978076
26.

Bifunctional polypyridyl-Ru(II) complex grafted onto gadolinium-based nanoparticles for MR-imaging and photodynamic therapy.

Truillet C, Lux F, Moreau J, Four M, Sancey L, Chevreux S, Boeuf G, Perriat P, Frochot C, Antoine R, Dugourd P, Portefaix C, Hoeffel C, Barberi-Heyob M, Terryn C, van Gulick L, Lemercier G, Tillement O.

Dalton Trans. 2013 Sep 14;42(34):12410-20. doi: 10.1039/c3dt50946j. Epub 2013 Jul 17.

PMID:
23860731
27.

A top-down synthesis route to ultrasmall multifunctional Gd-based silica nanoparticles for theranostic applications.

Mignot A, Truillet C, Lux F, Sancey L, Louis C, Denat F, Boschetti F, Bocher L, Gloter A, Stéphan O, Antoine R, Dugourd P, Luneau D, Novitchi G, Figueiredo LC, de Morais PC, Bonneviot L, Albela B, Ribot F, Van Lokeren L, Déchamps-Olivier I, Chuburu F, Lemercier G, Villiers C, Marche PN, Le Duc G, Roux S, Tillement O, Perriat P.

Chemistry. 2013 May 3;19(19):6122-36. doi: 10.1002/chem.201203003. Epub 2013 Mar 19.

PMID:
23512788
28.

In vivo evidence of the targeting of cartilaginous tissue by pyridinium functionalized nanoparticles.

Morlieras J, Chezal JM, Miot-Noirault E, Vidal A, Besse S, Kryza D, Truillet C, Mignot A, Antoine R, Dugourd P, Redini F, Sancey L, Lux F, Perriat P, Janier M, Tillement O.

Chem Commun (Camb). 2013 Apr 14;49(29):3046-8. doi: 10.1039/c3cc39106j.

PMID:
23467614
29.

Development of gadolinium based nanoparticles having an affinity towards melanin.

Morlieras J, Chezal JM, Miot-Noirault E, Roux A, Heinrich-Balard L, Cohen R, Tarrit S, Truillet C, Mignot A, Hachani R, Kryza D, Antoine R, Dugourd P, Perriat P, Janier M, Sancey L, Lux F, Tillement O.

Nanoscale. 2013 Feb 21;5(4):1603-15. doi: 10.1039/c2nr33457g.

PMID:
23334308

Supplemental Content

Loading ...
Support Center